SCHEMBL31738052

SCHEMBL31738052

Cc1ccc2c(cnn2C2CCCCO2)c1NC(=O)c1cnc(Cl)nc1N(C)N

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 1/20 0.37
▸ RXRB P28702 1/20 0.37
▸ RXRG P48443 1/20 0.37
▸ CYP4F2 P78329 2/20 0.35
▸ CYP4A11 Q02928 2/20 0.35
▸ POLQ O75417 1/20 0.33
▸ ATR Q13535 4/20 0.32
▸ DGAT2 Q96PD7 1/20 0.32
▸ NR3C1 P04150 3/20 0.32
▸ LMNA P02545 2/20 0.31
▸ PDE4B Q07343 2/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ PDE4A P27815 1/20 0.31
▸ PDE4C Q08493 1/20 0.31
▸ PDE4D Q08499 1/20 0.31
▸ MCL1 Q07820 1/20 0.31
▸ LCK P06239 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ PDK1 Q15118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31737727 0.89 RXRA (0.39) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL31430803 0.83 RXRA (0.40) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL31430725 0.81 RXRA (0.42) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL27227895 0.78 RXRA (0.47) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL31106070 0.78 LCK (0.43) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL31105893 0.76 LCK (0.41) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL25787278 0.73 CYP4F2 (0.43) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL20558385 0.73 RXFP1 (0.46) POLB
SCHEMBL20558353 0.73 LCK (0.43) POLBLCK
SCHEMBL30860912 0.72 RXRA (0.41) RXRARXRBRXRGCYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025242880-A1 THERAPEUTIC COMPOUNDS AND THEIR USE MY-T BIO LIMITED (GB) 2025-11-27 — — WO disclosed
Send feedback